Safety and Outcomes of Linezolid Use for Nocardiosis.

Natalie DavidsonMatthew J GriggSarah L McguinnessRobert J BairdNicholas M Anstey

Published in: Open forum infectious diseases (2020)

Linezolid is safe and efficacious in empirical treatment for moderate to severe nocardiosis in a monitored hospital setting, with 100% drug susceptibility and no difference in adverse events or outcomes compared with nonlinezolid regimens.

Keyphrases

methicillin resistant staphylococcus aureus
healthcare
adverse drug
early onset
drug induced
adipose tissue
skeletal muscle
smoking cessation